Access Ostase
Electrophoretic Separation, Alkaline Phosphatase Isoenzymes. 510(k) K232904, from Beckman Coulter (Chaska, MN). Product code CIN, class 2.
As of Nov 22, 2026, K232904 is an FDA 510(k) held by Beckman Coulter, substantially equivalent on Apr 15, 2024 after 210 days, with no recalls tied to it in FDA's recall database.
- Review time: 210 days
- Recalls: 0
The Access Ostase assay is a paramagnetic particle, chemiluminescent immunoassay for use with the Access Immunoassay Systems for the quantitative measurement of bone alkaline phosphatase (BAP), an indicator of osteoblastic activity, in human serum and plasma. This device is intended to be used as an aid in the management of postmenopausal osteoporosis and Paget's disease.
- Access Ostase Immunoenzymetric AssayK994278 · Beckman Coulter, Inc. · Mar 28, 2000
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 18, 2023
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1050
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files